word/phrase,value,class
journal,6.776499475131227e-05
intellectual,0.0006244635591750047
property,0.00024188316334637188
law,0.00033386492180574986
practice,0.00010612240333421405
vol,0.0002126542700349091
keep,0.0006119781950522329
sachin,0.004761321309752112
bindal,0.0053810433800845475
amit,0.0043988071377383565
koli*,0.0013452608450211369
ever,0.00020129971730750693
since,7.959180250066053e-05
india,0.004639767862873625
opened,0.0002925984781726257
patent,0.022643193216932617
regime,0.000626272062686918
january,0.00013666338591245935
include,0.00015949070252618182
product,0.0016313137740618952
ﬁeld,0.00244745424314334
pharmaceutical,0.008413428822611882
domain,0.0019644724846923827
kept,0.00028860698836471923
alive,0.0004894925322668529
interest,0.0001628629075461036
various,0.0003117731836893734
stakeholder,0.002113503539357004
rightly,0.0006085836632614935
also,1.3099984708962402e-05
known,0.0002874432481725454
pharmacy,0.0007719498042044429
world,0.00010543031311268404
global,0.0001490269514042082
market,0.0002361461334835636
leader,0.00033947468473327034
export,0.00048143467441876604
generic,0.0020106353812913863
drug,0.009145031328925959
united,0.0001422240180665358
state,9.058829621203524e-05
japan,0.00030290064673767317
well,9.058829621203524e-05
country,0.00010581786733439806
africa,0.0003114985332548387
europe,0.0002733267718249187
indian,0.003874756488821174
industry,0.00011654760449682953
turnover,0.0008541427238480413
billion,0.0008910486823158711
registering,0.0005926113350371143
growth,0.0002521822855939184
rate,0.0003159247667915951
per,0.00018330583994178318
cent,0.0005850337453198182
stood,0.0005926113350371143
r,0.001190330327438028
crore,0.0013452608450211369
one,1.0943465360525188e-05
largest,0.00029059382357482635
consumer,0.00023133760478210607
medicine,0.0011680535132961411
even,7.303420578375846e-05
though,0.00028423501061296117
accessibility,0.0005850337453198182
across,0.00032874482317496266
economically,0.0004021270762582773
weaker,0.0006543587962191781
section,0.0001683918821993907
remains,0.00018125708600687726
issue,0.00013095736195157325
equipped,0.0006257858019578135
balance,0.00020671858850854937
quid-pro-quo,0.0013452608450211369
requirement,0.0010162178432571675
jurisprudence,0.00045783116432078236
still,8.741649160927895e-05
evolving,0.00044552434115793555
recent,0.00013187894533658176
judicial,0.00028860698836471923
precedent,0.00037146022603478583
reafﬁrmed,0.0008804692922718094
ofﬁce,0.002051832676987616
proposed,0.000844787732548367
disclosure,0.003575541161709474
international,6.690189751992504e-05
nonproprietary,0.0028343138005544398
name,0.003143257875986565
application,0.0022048642924809656
relating,0.00053470588312644
pharmainventions,0.0013452608450211369
thereafter,0.0004894925322668529
organized,0.0003159247667915951
ceutical,0.0013452608450211369
meeting,0.0005649025561208377
different,9.070618625488945e-05
discus,0.0002136823133925098
proposal,0.002012997173075069
receive,0.00023287381350545257
feedback,0.0005850337453198182
feasibility,0.0007399642629029275
implementation,0.00019084085084393967
policy,6.088393429213625e-05
make,4.689081801249616e-05
mandatory,0.001720412910946836
rule,0.0002454919637687478
amended,0.0005974452561905502
provide,0.00020866557612859364
necessary,7.336598600984594e-05
basis,6.962188691828402e-05
put,9.474500353765373e-05
voiced,0.0006004548587410448
concern,0.00024068383695904124
ﬁnally,0.0009693710385387049
decided,0.00020947809873608826
reject,0.0008313554790449635
least,6.740516637535536e-05
making,0.00012319838173713475
remain,0.00012781978228778668
unchanged,0.0005706082571055911
go,8.900295409719582e-05
credit,0.0004620887690382244
speciﬁcation,0.0027026491532930277
removed,0.00020535150480101457
recently,0.00024235092221094342
issued,0.00048463923996085856
guideline,0.0009011848951526258
examination,0.0006670070518753937
however,1.6620314925946357e-05
instruct,0.0006871272367077922
examiner,0.004319135006349335
search,0.010227441462089369
prior,0.0013639876520666954
art,0.0005569750953462721
based,0.00010842251690010711
disclosed,0.0010091336760643158
case,4.310473433571198e-05
second,9.006952597655708e-05
medical,0.0012683223865843775
use,1.972248685970353e-05
invention,0.0021808765798238634
author,0.00023500718323760244
koli,0.00403578253506341
associate,0.0003419721128312694
partner,0.0012372714300996335
gurgaon,0.0026905216900422737
attempt,0.00019787740093282362
explore,0.0005933250889711226
tool,0.0014691660754147416
searching,0.0022891558216039114
whether,0.0001259363988962964
would,7.27647795045199e-05
indeed,0.00022402725144655982
thing,0.00027735414121560323
simpler,0.0014239762228489916
directed,0.0002846855283183003
ask,0.00030080187554856383
applicant,0.004256066297289695
disclose,0.0017662727044849775
substance,0.002860581490478622
claimed,0.0003946401446194496
event,0.00023493108417679568
give,0.00014673197201969188
information,0.00015536421277632045
upon,0.00013924377383656803
request,0.0004273646267850196
required,0.00018125708600687726
seek,0.0001297550107351911
ascertain,0.0005207317707401477
examine,0.00046267520956421213
discussed,0.00012878530210186563
held,7.336598600984594e-05
dropped,0.001251571603915627
general,6.29681994481482e-05
background,0.00018704159524816018
ofﬁcial,0.001149681063528193
given,5.183812298678183e-05
designated,0.0006889955221059193
health,0.0030060958734612142
organization,0.00039512142286507777
identiﬁes,0.0006004548587410448
active,0.0008268743540341975
ingredient,0.0019977131145442755
unique,0.000352033160411292
globally,0.0004894925322668529
recognized,0.00034964896820626796
email,0.0002375468232079324
thank,0.0003137006938206004
dr,0.0002846855283183003
deepa,0.0013452608450211369
kachroo,0.0013452608450211369
tiku,0.0013452608450211369
providing,0.00012024219257049055
unconditional,0.0008092893138022873
guidance,0.0005578587900874356
critical,0.00016665322208623325
comment,0.00044708085421262455
without,2.0489219839603905e-05
paper,8.340472792165672e-05
could,3.037632270564941e-05
written,0.00018956724346985045
fullest,0.0007898407492683708
view,7.59275722449509e-05
expressed,0.00016211463997239454
solely,0.0002642672551510583
alone,0.00019996528057138774
way,1.2296562300752148e-05
represent,0.00016895754650967341
aiswariya,0.0013452608450211369
chidambaram,0.0013452608450211369
insight,0.0002925984781726257
snapshot,0.0007255387746887002
july,0.0002204509525424921
available,0.0005165751333380571
frostcomsublibdisplay-market-insight-topdoid=,0.0013452608450211369
may,5.960902506633493e-05
business,0.00011022547627124606
ministry,0.0002642672551510583
external,0.00030290064673767317
affair,0.00023597827298559314
government,0.00010909516230595813
investment,0.0001986387633877487
technology,0.00039512142286507777
promotion,0.0002751727101535998
division,0.00024231961998042928
industryserviceslanding,0.0013452608450211369
june,0.0004661904179873181
controller,0.0008541427238480413
design,0.00016099424920848588
trade,0.0002361461334835636
mark,0.00015987944645166254
field,0.0005388944913019034
october,0.00025563956457557335
para,0.0006595100033724864
new,3.098572334113049e-05
therapeutic,0.001217167326522987
us,0.0001565680156717295
published,0.0003314568897720961
oxford,0.00012399887746060868
university,2.8054057853128415e-05
press,4.173311522571873e-05
right,0.00010857527169740239
reserved,0.00030080187554856383
doijiplpjpv,0.0009103158939072633
advance,0.00019600911553469653
access,4.3708245804639476e-05
publication,0.00011563342126172759
table,0.0038300765709377107
understanding,9.308931086035177e-05
indication,0.0002751727101535998
n-hydroxyphenylethanamide,0.0013452608450211369
paracetamol,0.001190330327438028
anti-pyretic,0.0013452608450211369
-acetoxybenzoic,0.0013452608450211369
acid,0.0023158494126133285
aspirin,0.00755817013481184
analgesic,0.0010997017844345891
antipyretic,0.0013452608450211369
anti-inﬂammatory,0.001190330327438028
easy,0.0002488461417298317
remember,0.0004536531456783843
unlike,0.0002770431603106219
union,0.00019084085084393967
pure,0.00044552434115793555
applied,0.00019450353602161834
chemistry,0.0013513245766465138
nomenclature,0.004046446569011436
apart,0.00029059382357482635
system,0.0001351042889648356
british,0.00017963149710063447
approved,0.0018174038804260387
adopted,0.00025563956457557335
identify,0.0003264813500921648
provides,0.00016523261124964643
example,3.271071432255326e-05
question,5.55174439937794e-05
using,0.0002454919637687478
raised,0.00018207433550745982
number,8.884094870115581e-05
including,8.884094870115581e-05
following,0.0001311247374139184
suddenly,0.0006004548587410448
sought-after,0.0010353998098549186
beneﬁcial,0.0005263907436178951
regarding,0.00013766796058951652
might,5.594021799081999e-05
extra,0.0004894925322668529
burden,0.0008899876334566839
seeking,0.0003791344869397009
vested,0.0005098263157376061
group,3.912646773175249e-05
agency,0.00034491839518604236
fueling,0.0013452608450211369
sudden,0.0019332691495498862
need,3.9787933040049564e-05
related,0.0003820354359949842
method,0.001006544773585161
synthesis,0.0038094613901115686
string,0.018138469367217504
type,0.00032007458791885856
jurisdiction,0.0006326122067217875
result,0.0004760368661016227
title,0.0020683069398615738
acetoxybenzoic,0.0013452608450211369
cooperation,0.0002555689790119943
treaty,0.00019600911553469653
composition,0.0030181296123325905
rotigotine,0.017488390985274778
rotigotina,0.0013452608450211369
thiophen,0.0013452608450211369
tetrahydronaphthalen,0.0013452608450211369
thienyl,0.0013452608450211369
tetrahydro,0.0013452608450211369
naphthalenol,0.0013452608450211369
abstract,0.0014957761937475686
claim,0.0005893715876978675
exclamation,0.0013452608450211369
wildcard,0.0013452608450211369
represents,0.00021796712491290671
zero,0.0006004548587410448
unlimited,0.0005381575387591735
character,0.0001973200723097248
earlier,0.0001230537703890712
premise,0.00036580125315703837
help,0.00013072894469180713
conduct,0.00023133760478210607
effectively,0.00020535150480101457
hypothesis,0.0006349102316852615
designed,0.0005687017304095513
sample,0.0007429204520695717
shown,0.000671209659178267
found,0.00023194902715557915
used,0.00015179152366014996
two,6.075264541129882e-05
relevant,0.0011369400424518447
four,0.00046253368504691036
document,0.0009778352997308495
fact,6.047079083659297e-05
appeared,0.0005503454203071996
missed,0.004122763420246753
common,5.663980381826457e-05
thus,9.821945777813966e-05
prove,0.00026074722193937256
effective,0.00025757060420373125
instance,0.00011563342126172759
conﬁrm,0.0007255387746887002
provisional,0.0005850337453198182
conclusion,0.00041702363960828353
another,2.6530600833553512e-05
study,0.0001988764264141509
treatment,0.0004273646267850196
parkinson,0.002380660654876056
disease,0.0013130424523620152
restless,0.0010997017844345891
leg,0.0007898407492683708
syndrome,0.0009103158939072633
trial,0.0006789493694665407
changed,0.00018207433550745982
subject,0.0001001110033715101
matter,0.00012034191847952062
molecule,0.000755385376324154
broaden,0.0006756622883232569
presumption,0.0004994282786360689
old,0.00015008879420594438
nevertheless,0.00018330583994178318
miss,0.0005850337453198182
generally,9.308931086035177e-05
reached,0.000243933471680305
mentioned,0.0004863439199171836
captured,0.0027469869859246938
three,0.00011048562992403205
belong,0.0003345620146837437
family,0.00021227210373423456
discloses,0.0008541427238480413
comprising,0.0004376808174540051
addition,0.00016053517770671835
salt,0.0021766163240661005
remaining,0.0002808316830313472
talk,0.0003470522744505665
novel,0.0003548957981544969
word,0.00022464409387119697
whointmedicinesservicesinninnquidanceen,0.0013452608450211369
april,0.000673338403923589
ﬁnds,0.0005263907436178951
term,2.1158780088123512e-05
appear,0.0004729991517697215
within,1.4027028926564208e-05
n-number,0.0013452608450211369
conducted,0.0004750936464158648
total,0.0009011848951526258
database,0.0012372714300996335
december,0.00025371683051986644
wn,0.0013452608450211369
operator,0.0005045668380321579
polymorph,0.002380660654876056
axitinib,0.006726304225105684
pyridin,0.00403578253506341
indazol,0.0013452608450211369
sulfanyl,0.0013452608450211369
highly,0.0004282790859920839
already,0.00015128584819553242
among,0.00019563064292158936
listed,0.00026074722193937256
orange,0.007283603824220585
book,0.0009707394942546113
book-listed,0.0026905216900422737
food,0.0011623752942993054
administration,0.0009131860143718206
approval,0.0027451738061014816
fail,0.0003470522744505665
efﬁcient,0.000515212539967233
obtain,0.0003766017040805585
crystalline,0.0021994035688691783
form,7.228325638241198e-05
disclosing,0.00349606103132466
corresponding,0.0011588043670956458
currently,0.00014070906177866745
molecular,0.0007255387746887002
formula,0.00047997971410215225
structural,0.00041567773952248176
diagram,0.0007719498042044429
clinical,0.0006756622883232569
code,0.00022086999025140006
systematic,0.00041221228267278103
chemical,0.0017662727044849775
service,9.978696520139544e-05
registry,0.000532196719124683
etc,0.00021796712491290671
tried,0.0003772662015415738
tested,0.0009988565572721377
well-established,0.0006444230498499621
worldwide,0.0003496363204490486
ing,0.0006257858019578135
data,0.00017363871214761968
major,9.226604109205891e-05
requires,0.0004251960807073562
sometimes,0.00017245919759302118
conﬂict,0.0003862681223652153
referred,0.00017963149710063447
national,4.818883758827465e-05
de´nominations,0.0013452608450211369
commune,0.0009103158939072633
francaises,0.0013452608450211369
japanese,0.0003862681223652153
similar,0.00016156350933345287
purpose,9.677182511616105e-05
difference,0.00012399887746060868
flurothyl,0.0013452608450211369
whereas,0.00022981188220684155
flurotyl,0.0013452608450211369
lead,0.00010235124750656265
confusion,0.0007912957095849843
concluded,0.00020809408509183647
create,9.725176801080917e-05
prosecution,0.000466429050837948
link,0.000488450570910051
good,5.385450311115096e-05
idea,0.00010494529003848415
take,5.183812298678183e-05
linking,0.0008753616349080102
unnecessarily,0.0007255387746887002
cumbersome,0.0006647568333207153
ﬁling,0.0015621953122204428
best,0.00030963776293589917
responsibility,0.0001973200723097248
regulatory,0.0021501077601858063
body,0.00010756979169126669
stage,0.0009930594457630258
time,1.3246450014741097e-05
ﬁled,0.000860206455473418
soon,0.000243933471680305
research,7.695905618455235e-05
development,3.400263329297305e-05
show,7.871537782785453e-05
promise,0.0003602820223841238
accordingly,0.0002714781220799388
compound,0.0010885633773636458
unlikely,0.0002625003092743759
patenting,0.001919918856408609
actually,0.0001565680156717295
laboratory,0.0004620887690382244
acronym,0.0007719498042044429
naming,0.0006349102316852615
therefore,5.247476114111933e-05
practical,0.00033791509301934683
challenge,0.00011931280458116356
almost,0.0001230537703890712
never,0.00011931280458116356
besides,0.000430103227736709
allow,0.00012117546110547171
adding,0.00041221228267278103
inclusion,0.0005250006185487518
present,7.182066652166094e-05
viable,0.00039886398926341425
approach,5.178807092544015e-05
internationally,0.00029462127468751623
done,0.00014070906177866745
applying,0.0002642672551510583
linkage,0.0026036588537007377
meant,0.00020129971730750693
prevent,0.00014587135796545464
infringement,0.0005180155548912199
followed,0.00017482448410313398
several,0.00012463348723544174
member,0.0001217678685842725
closer,0.0003602820223841238
collaboration,0.00033947468473327034
regulator,0.0006992122062649321
website,0.0003137006938206004
repository,0.0005263907436178951
exercise,0.00020947809873608826
kyoto,0.0008092893138022873
bioinformatics,0.0009855233234894753
center,0.00025900777744560996
obtained,0.00021941384510530427
presented,0.00022402725144655982
performed,0.0006691240293674874
acting,0.0003181711926291916
dopamine,0.0013452608450211369
agonist,0.0013452608450211369
indicated,0.00028663765853813517
expiry,0.0013513245766465138
november,0.0002595100214703822
march,0.0004516523747809633
september,0.00026735294156322
submitted,0.0002572817650896719
sponsorapplicant,0.0013452608450211369
depending,0.0003273897151761304
status,0.0005036046617929519
publishes,0.0006871272367077922
list,0.0002461075407781424
mapped,0.0008092893138022873
year,2.5309190748316967e-05
back,0.00011746554208839784
decree,0.000466429050837948
gazette,0.002097636618794796
federal,0.000243933471680305
mexico,0.0004495517922706254
regulation,0.00024235092221094342
industrial,0.00036661167988356636
amendment,0.0005320965608523034
imposed,0.0002375468232079324
mexican,0.0013295136666414307
institute,0.00013566330599171713
obligation,0.0001784200172275118
publish,0.0004191977727341675
special,9.809364278912062e-05
listing,0.00043385991262682706
allopathic,0.0013452608450211369
brought,0.00013170714095502592
beneﬁt,0.0003071582514551152
owner,0.00035793841374349067
authority,0.0003706119554758266
grant,0.0003066098573537328
registration,0.0006100386235781071
covering,0.0003924773407910416
marketing,0.0010641931217046068
inform,0.00033947468473327034
holder,0.0004565930071859103
licensee,0.00048468551926935245
existing,0.000325354555893337
licence,0.00035225058989283404
must,9.070618625488945e-05
declaration,0.0002521822855939184
infringe,0.001426112828380168
work,2.8375322358673963e-05
determine,0.00014173202690245207
pending,0.00044156817612124436
indicates,0.0002770431603106219
valid,0.0003159247667915951
infringed,0.0004620887690382244
opportunity,0.00011381619589109803
demonstrate,0.00025900777744560996
alternative,0.00013566330599171713
similarly,0.00017482448410313398
china,0.0005811876471496527
maintains,0.0008991035845412509
separate,0.00018454416715016117
track,0.0004227741288614592
compoundcomposition,0.0013452608450211369
check,0.0009073062913567685
certify,0.00094477126685148
acknowledge,0.00028663765853813517
liability,0.0003893511710987137
damage,0.0001986387633877487
resulting,0.0001986387633877487
future,4.437052033182222e-05
ﬁnding,0.0004264086396630479
frequent,0.0004620887690382244
inspection,0.0005570575938413866
order,3.3370334457170036e-05
avoid,0.00018330583994178318
copying,0.000430103227736709
patented,0.00040543850703821034
justiﬁed,0.00048468551926935245
aim,0.00012494799773769065
professional,0.00041070300960202913
universally,0.0004994282786360689
existence,0.0001490269514042082
identiﬁcation,0.000532196719124683
safe,0.00039564785479249216
prescription,0.0006085836632614935
dispensing,0.0010353998098549186
patient,0.000532196719124683
communication,0.00017245919759302118
exchange,0.00020535150480101457
role,9.006952597655708e-05
mainly,0.00023442065351560447
commercial,0.00022402725144655982
reader,0.0003114985332548387
recall,0.00044552434115793555
bayer,0.002641407876815428
cipla,0.00094477126685148
high,0.0001422240180665358
court,0.0004661904179873181
supreme,0.0005145635301793438
clearly,0.00024314326620745167
ruled,0.00037146022603478583
overlap,0.0009417105687494086
apply,0.0002404843851409811
context,4.570098550654861e-05
equivalence,0.0007399642629029275
evaluation,0.0003419721128312694
engine,0.0005706082571055911
docsqueryaicfm,0.0013452608450211369
report,0.0001437216240862727
joint,0.0002808316830313472
commission,0.00017245919759302118
commerce,0.00033947468473327034
device,0.0003250491965190431
subgroup,0.0009103158939072633
task,0.00022233568395846456
force,9.557747187199196e-05
august,0.00033791509301934683
beijing,0.0006647568333207153
sa´nchez,0.0013452608450211369
reform,0.00030080187554856383
introduced,0.00019341004567538538
managing,0.00032044042521028014
no,0.0005570575938413866
delhi,0.0006085836632614935
judgement,0.00048468551926935245
pronounced,0.0006349102316852615
appeal,0.00016895754650967341
civil,0.00018454416715016117
disposed,0.0006349102316852615
finston,0.001190330327438028
consulting,0.0005637302532157394
serial,0.0008541427238480413
almotriptan,0.0026905216900422737
hit,0.0082965586905196
dimethylaminoethyl,0.0013452608450211369
indol,0.0013452608450211369
pyrrolidin,0.0013452608450211369
alvimopan,0.0026905216900422737
ibrutinib,0.0026905216900422737
hydroxyphenyl,0.0013452608450211369
dimethylpiperidin,0.0013452608450211369
methyl,0.001190330327438028
phenylpropanoyl,0.0013452608450211369
phenoxyphenyl,0.0013452608450211369
pyrazolo,0.0013452608450211369
pyrimidin,0.0013452608450211369
piperidin,0.0026905216900422737
bortezomib,0.0026905216900422737
pyrazin,0.0013452608450211369
phenylalanin,0.0013452608450211369
leucin,0.0013452608450211369
boronic,0.0013452608450211369
crizotinib,0.0026905216900422737
dichloro,0.0013452608450211369
ﬂuoro,0.0013452608450211369
pyrazol,0.0013452608450211369
prasugrel,0.0026905216900422737
cyclopropyl,0.0013452608450211369
tetrahydrothieno,0.0013452608450211369
levomilnacipran,0.0026905216900422737
diethyl,0.0013452608450211369
phenyl,0.0013452608450211369
cyclopropan,0.0013452608450211369
carboxamid,0.0013452608450211369
allocated,0.000532196719124683
advice,0.0003602820223841238
expert,0.00036661167988356636
advisory,0.00040879973563263017
panel,0.0003159247667915951
pharmacopoeia,0.0009855233234894753
preparation,0.00036861283097561903
process,3.7834455525062e-05
selection,0.00032044042521028014
follows,0.0001973200723097248
main,0.00010321258764529973
step,0.00011746554208839784
requestapplication,0.0013452608450211369
made,1.2296562300752148e-05
company,0.00012494799773769065
review,7.949013593249528e-05
selected,0.00027331778258343753
time-period,0.001190330327438028
objection,0.0003548957981544969
lapsed,0.0007399642629029275
recommended,0.0003862681223652153
importantly,0.0002966625444855613
speciﬁcally,0.00033947468473327034
human,9.978696520139544e-05
substantial,0.00017482448410313398
regard,0.00010321258764529973
description,0.0005111379580239886
risk,0.00015115570548894245
losing,0.0004376808174540051
novelty,0.0004227741288614592
due,0.00020298642772803726
delay,0.0003802267413712657
obtaining,0.0006318495335831902
lack,7.794329592234335e-05
clarity,0.00044552434115793555
consequence,0.00013466768078471781
mandate,0.0003924773407910416
possible,7.309973743375126e-05
loss,0.0001565680156717295
decides,0.0005505783723756014
withhold,0.0007898407492683708
want,0.00018207433550745982
misuse,0.0004944052023163796
third,8.578681962627377e-05
party,7.261213204264378e-05
frivolous,0.0008541427238480413
opposition,0.0002696534793806852
invalidation,0.0007719498042044429
proceeding,0.00020264216872671853
particularly,7.036570620504725e-05
ground,0.00010149321386401863
act,0.00012127797503854666
difﬁculties,0.00043385991262682706
specifying,0.0006170192866213336
component,0.00021227210373423456
markush,0.0026905216900422737
representation,0.0004596237644136831
deﬁnes,0.00048468551926935245
shall,0.00016099424920848588
contain,0.00024231961998042928
performing,0.0007372256619512381
applicantinventor,0.0013452608450211369
entitled,0.000185789393152947
protection,4.503476298827854e-05
reliable,0.00048468551926935245
source,7.488136462373233e-05
describing,0.000430103227736709
aid,0.00033947468473327034
enabling,0.0003548957981544969
person,0.00010321258764529973
skilled,0.000532196719124683
carry,0.00022233568395846456
wise,0.0006349102316852615
imposes,0.0004536531456783843
overcome,0.0003743443626884134
important,2.1684503380021424e-05
legal,0.00013334223626277234
barrier,0.00029059382357482635
legally,0.00024555906058654783
speaking,0.0003345620146837437
agreement,0.00018289158500804238
trade-related,0.0006871272367077922
aspect,5.0420987217905346e-05
said,0.00012685841525993322
cannot,5.247476114111933e-05
discriminate,0.0007399642629029275
ﬁelds,0.0005045668380321579
rejecting,0.0005777046464445685
saved,0.000515212539967233
potentially,0.00023287381350545257
accused,0.00045783116432078236
discrimin,0.0013452608450211369
herein,0.0006543587962191781
symbol,0.0003050193117890536
indicate,0.00024231961998042928
collection,0.00015008879420594438
structure,0.00011931280458116356
commonly,0.00028663765853813517
text,0.00015222773387200598
ation,0.0009855233234894753
contrary,0.00019600911553469653
careful,0.00039564785479249216
thought,0.0001784200172275118
require,0.00012685841525993322
came,0.0001437921105121659
surprise,0.0005045668380321579
pharma,0.0007898407492683708
debate,0.00026341428191005184
longer,0.00012117546110547171
restricted,0.0002471965586751681
evokes,0.000755385376324154
serious,0.00021087073557392918
emotive,0.0007719498042044429
certainly,0.00019600911553469653
faced,0.0002987226280952751
dilemma,0.00039886398926341425
address,0.00011838726500032833
admirably,0.0010997017844345891
took,0.00014587135796545464
reasonable,0.00022086999025140006
balanced,0.00043385991262682706
pursuant,0.00039564785479249216
elaborate,0.0004708552843747043
discussion,7.412239109516533e-05
augur,0.0010997017844345891
fraternity,0.00094477126685148
thoroughly,0.000532196719124683
usefulness,0.0006543587962191781
great,8.498996498764247e-05
impact,0.00010321258764529973
initiating,0.0006992122062649321
nationwide,0.0007898407492683708
outlined,0.0003772662015415738
drawn,0.00023912645868280456
ie,0.00020671858850854937